Ultromics is unlocking the full potential of echocardiography for advanced heart disease detection and prediction. Discover the power of our groundbreaking AI SaaS platform.
This study evaluates the role of echocardiography and AI in the cardiac amyloidosis referral pathway, showing improved detection rates and reduced unnecessary referrals compared with traditional echo red flags.
Discover how AI-based External Validation of Artificial Intelligence for Detection of Heart Failure with Preserved Ejection Fraction the latest research
Discover how Three Rules to Find Them All - Clinical Risk Scores in HFpEF explores the latest research on AI-based Echo Diagnostics.
Discover how Integrating Artificial Intelligence Pipelines Into The Diagnosis Of Cardiomyopathies explores the latest research on AI-based Echo Diagnostics.
Discover how Impact of Technical Changes in Artificial Intelligence Based Detection of Heart Failure with Preserved Ejection Fraction and Model Performance and Prognostication explores the latest research on AI-based Echo Diagnostics.
Discover how Clinical Utility Of Screening For Transthyretin Cardiac Amyloidosis In Heart Failure With Preserved Ejection Fraction explores the latest research on AI-based Echo Diagnostics.
Discover how Deep Learning for Detection of Preclinical Heart Failure in the Multi-Ethnic Study of Atherosclerosis explores the latest research on AI-based Echo Diagnostics.
Discover how Clinical Utility Of An AI-Based Model For Detecting Heart Failure With Preserved Ejection Fraction (Hfpef) Through Decision Curve Analysis explores the latest research on AI-based Echo Diagnostics.
Sign-up to hear about the latest news.
Sign up to newsletter
cases processed
